Loading...
You have changed your country from
to
. Please be aware that this will change the currency in the purchasing process.
Related products
- Secondary antibodies
Reassurance, Refunds & Replacements
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Overview
Product name
Anti-KAT13A / SRC1 antibody - Aminoterminal end
See all KAT13A / SRC1 products (6) ...
Description
Rabbit polyclonal to KAT13A / SRC1 - Aminoterminal end
Tested applications
WB, ELISAmore details
Cross reactivity
Reacts with
Human
Immunogen
KLH-conjugated synthetic peptide selected from the N-terminal region of human KAT13A / SRC1.
Positive control
Transfected 293 cell lysate.
Properties
Form
Liquid
Storage instructions
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Storage buffer
Preservative: 0.09% Sodium Azide
Constituents: PBS
Concentration
Concentration information loading...
Purity
Ammonium Sulphate Precipitation
Clonality
Polyclonal
Isotype
IgG
Research areas
Metabolism >> Types of disease >> Cancer
Metabolism >> Pathways and Processes >> Metabolic signaling pathways >> Lipid and lipoprotein metabolism >> Lipid metabolism
Cancer >> Cancer Metabolism >> Metabolic signaling pathway >> Metabolism of lipids and lipoproteins
Cancer >> Oncoproteins/suppressors >> Oncoproteins >> Signal transducers
Epigenetics and Nuclear Signaling >> Chromatin Modifying Enzymes >> Acetylation >> HAT
Epigenetics and Nuclear Signaling >> Nuclear Signaling Pathways >> Nuclear Receptors >> Co-activators/co-repressors
Signal Transduction >> Signaling Pathway >> Nuclear Signaling >> Nuclear Hormone Receptors >> Co-activators/co-repressors
Epigenetics and Nuclear Signaling >> Transcription >> Domain Families >> HLH / Leucine Zipper >> HLH
Epigenetics and Nuclear Signaling >> Chromatin Modifying Enzymes >> Acetylation
-
Western blot - KAT13A / SRC1 antibody - Aminoterminal end (ab71531)
(enlarge)
Applications
Show applications key
Our Abpromise guarantee covers the use of ab71531 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
WB: 1/50 - 1/100. Predicted molecular weight: 160 kDa.
ELISA
ELISA: 1/1000.ELISA: 1/1000.
Target
Function
Nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in a hormone-dependent fashion. Involved in the coactivation of different nuclear receptors, such as for steroids (PGR, GR and ER), retinoids (RXRs), thyroid hormone (TRs) and prostanoids (PPARs). Also involved in coactivation mediated by STAT3, STAT5A, STAT5B and STAT6 transcription factors. Displays histone acetyltransferase activity toward H3 and H4; the relevance of such activity remains however unclear. Plays a central role in creating multisubunit coactivator complexes that act via remodeling of chromatin, and possibly acts by participating in both chromatin remodeling and recruitment of general transcription factors. Required with NCOA2 to control energy balance between white and brown adipose tissues. Required for mediating steroid hormone response. Isoform 2 has a higher thyroid hormone-dependent transactivation activity than isoform 1 and isoform 3.
Tissue specificity
Widely expressed.
Involvement in disease
Note=A chromosomal aberration involving NCOA1 is a cause of rhabdomyosarcoma. Translocation t(2;2)(q35;p23) with PAX3 generates the NCOA1-PAX3 oncogene consisting of the N-terminus part of PAX3 and the C-terminus part of NCOA1. The fusion protein acts as a transcriptional activator. Rhabdomyosarcoma is the most common soft tissue carcinoma in childhood, representing 5-8% of all malignancies in children.
Sequence similarities
Belongs to the SRC/p160 nuclear receptor coactivator family.
Contains 1 basic helix-loop-helix (bHLH) domain.
Contains 1 PAS (PER-ARNT-SIM) domain.
Domain
The C-terminal (1107-1441) part mediates the histone acetyltransferase (HAT) activity.
Contains 7 Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs. LXXLL motifs 3, 4 and 5 are essential for the association with nuclear receptors. LXXLL motif 7, which is not present in isoform 2, increases the affinity for steroid receptors in vitro.
Post-translational
modifications
Sumoylated; sumoylation increases its interaction with PGR and prolongs its retention in the nucleus. It does not prevent its ubiquitination and does not exert a clear effect on the stability of the protein.
Ubiquitinated; leading to proteasome-mediated degradation. Ubiquitination and sumoylation take place at different sites.
Phosphorylated upon DNA damage, probably by ATM or ATR.
Cellular localization
Nucleus.
Target information above from: UniProt accessionQ15788
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Alternative names
- NY REN 52 antigen antibody
- Protein Hin 2 antibody
- SRC 1 antibody
see all
Database links
- Entrez Gene: 8648 Human
- Omim: 602691 Human
- SwissProt: Q53SX3 Human
- SwissProt: Q15788 Human
- Unigene: 412293 Human
- Unigene: 596314 Human
Anti-KAT13A / SRC1 antibody - Aminoterminal end images:
Western blot - KAT13A / SRC1 antibody - Aminoterminal end (ab71531)
All lanes : Anti-KAT13A / SRC1 antibody - Aminoterminal end (ab71531) at 1/50 dilution
Lane 1 : Non-transfected 293 cell line lysate
Lane 2 : KAT13A / SRC1 transfected 293 cell line lysate
Lysates/proteins at 2 µg per lane.
Predicted band size : 160 kDa
Observed band size : 200 kDa (why is the actual band size different from the predicted?)
References for Anti-KAT13A / SRC1 antibody - Aminoterminal end (ab71531)
ab71531 has not yet been referenced specifically in any publications.
Publishing research using ab71531? Please let us know so that we can cite the reference in this datasheet
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"